Inactive Instrument

Samsara Vision, Inc.

SMSA

US79600A1051

Medical Equipment, Supplies & Distribution

Samsara Vision, Inc. has filed an IPO.

November 03, 2021 at 12:00 am EDT

Samsara Vision, Inc. has filed an IPO.

Security Name: Common Stock
Security Type: Common Stock

Transaction Features: Sponsor Backed Offering

Latest news about Samsara Vision, Inc.

Samsara Vision Announces First U.S. Surgeries of the Sing Imt, for Age-Related Macular Degeneration as Part of the Concerto Study	22-07-11	CI
Samsara Vision and Lansheng Medical “Myvision” Announce Collaboration to Commercialize the Sing Imt™ in China	22-06-08	CI
Samsara Vision, Inc. to Initiate A U.S. Pma Supplemental Study of the Sing Imt™, A New-Generation Technology for Age-Related Macular Degeneration	22-04-20	CI
Samsara Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11	CI
Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	22-03-10	CI
Samsara Vision, Inc. Announces the First Three Successful Clinical Cases in Italy Using Its Sing Imt™	22-02-22	CI
Samsara Vision, Inc. has filed an IPO.	21-11-03	CI
Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	21-09-30	CI
VisionCare Ophthalmic Technologies, Inc. Announces Appointment of Thierry Clidiere to Board of Directors	16-03-10	CI
VisionCare Ophthalmic Technologies Announces Executive Appointments	15-09-09	CI
Visioncare Ophthalmic Technologies Announces Executive Changes	15-04-15	CI
VisionCare Ophthalmic Technologies, Inc. announced that it has received funding	14-12-15	CI
VisionCare Ophthalmic Technologies, Inc. Announces Board Changes	14-04-15	CI
VisionCare Ophthalmic Technologies, Inc. Announces Management Promotions	14-03-28	CI
VisionCare Ophthalmic Technologies, Inc. Secures Up to $15 Million to Accelerate Growth of its Novel Treatment for Age-Related Macular Degeneration	13-09-17	CI
VisionCare Ophthalmic Technologies, Inc. announced that it has received $15 million in funding from Life Sciences Alternative Funding LLC.	13-09-17	CI
Visioncare Ophthalmic Technologies, Inc. Receives Health Canada Medical Device License for AMD Treatment	12-11-27	CI
VisionCare Ophthalmic Technologies, Inc. Receives Health Canada License for Telescope Prosthesis for End-Stage Macular Degeneration	12-11-08	CI
Florida Medicare Contractor Covers VisionCare Ophthalmic Technologies, Inc.'s Telescope Implant for End-Stage Macular Degeneration	12-10-09	CI
VisionCare Ophthalmic Technologies, Inc. Expands its CentraSight(TM) Provider Teams Nationwide	12-06-08	CI

Samsara Vision, Inc is a specialty medical device company. The Company is involved in bringing vision and freedom back to patients suffering from late-stage conditions of the retina. It is engaged in the research, development, manufacturing, and marketing of ophthalmic devices and technologies that are intended to improve vision and quality of life for individuals with untreatable retinal disorders, particularly Age-Related Macular Degeneration (AMD). Its product line consists of its first-generation implantable miniature telescope (IMT), which it refers to as WA IMT; its Smaller-Incision, New Generation (SING) IMT, which it refers to as SING IMT; and its Tsert delivery system. Its WA IMT is the implantable medical device that works similarly to the telephoto lens of a camera, which enables improvement in vision and quality of life for individuals with the most advanced form of AMD, commonly referred to as late-stage AMD.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+15.96%	132B
SMITH & NEPHEW PLC	-4.08%	11.44B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-4.61%	8.52B
GLAUKOS CORPORATION	+43.74%	5.77B
INSPIRE MEDICAL SYSTEMS, INC.	-25.34%	4.5B
AXONICS, INC.	+7.81%	3.43B
ENOVIS CORPORATION	-15.52%	2.64B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-12.58%	2.05B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-14.31%	1.93B

Medical Devices & Implants